我们从分子信息化临床试验中学到什么关于胸腺瘤和胸腺癌的现状和未来方向?
Rohan Maniar1, Patrick J Loehrer1
1Division of Hematology & Oncology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Cancers
|January 23, 2024
概括
针对性治疗对胸膜上皮瘤 (TETs) 显示了适度的结果,包括胸膜瘤和胸膜癌. 未来的研究重点是新的组合和生物标志物,以提高治疗这些罕见癌症的疗效和安全性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 胸腺上皮瘤 (TETs),包括胸腺瘤和胸腺癌,是起源于胸腺的罕见恶性瘤.
- TETs,特别是胸腺瘤,由于胸腺在免疫细胞发育中的作用,经常与神经瘤自身免疫性疾病有关.
研究的目的:
- 审查当前的景观和未来的方向针对胸膜上皮瘤的向疗法.
- 突出开发TET有效治疗的挑战和机会,重点关注生物标志物发现和组合策略.
主要方法:
- 对针对TETs进行调查的向治疗的现有文献的审查.
- 对正在进行的临床试验和新兴治疗策略的分析.
主要成果:
- 针对TETs进行研究的向疗法迄今为止已经产生了适度的临床益处.
- 以前的治疗包括体静止素受体剂,铁氨酸激酶抑制剂 (KIT,EGFR),表观遗传调节剂和抗血管生成药物.
- 目前治疗疗效的一个显著限制是缺乏强大的生物标志物.
结论:
- 尽管得到了适度的结果,但向疗法仍然是TETs积极研究的领域.
- 未来的战略包括探索新的组合疗法,早期疾病治疗和先进的生物标志物识别,以改善患者的治疗结果.
- 目标识别和药物输送方面的技术进步可能为胸膜瘤开辟新的治疗机会.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
1.8K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K